I am an entrepreneurial executive with a finance background, general management experience and international exposure. I have had pivotal roles in 3 tech start-ups including an MBO from a multi-national company. My experience is in fast-moving technology businesses, from pre-revenue start-ups to multi-national companies within 3 NYSE, 2 NASDAQ and 5 VC backed organisations.
My sector experience centres on high-tech (hardware and software); nanotech / semiconductor; healthcare / medtech, specifically In-vitro Diagnostics, Medical Imaging (PET/CT, Image Guided Surgery and General Radiology), PET Biomarkers and Connected Health / mHealth; and, cyber security.
I have acted as an Innovate UK grant examiner; was on the Industry Advisory Group for the establishment of the UK’s Precision Medicine Catapult; have advised King’s College London on commercialization strategies for new imaging technologies; and, was on the Diagnostics Advisory Council of the Oxford Academic Health Science Network.
I have lectured and mentored on the Goldman Sachs “10,000 Small Business program” and taught on the Chevening Rolls-Royce Science and Innovation Leadership Programme, both run at Oxford University. I have invested in early-stage companies and am an active member of the Oxford entrepreneurial community.
Speaker sessions
14:45 - 15:45
Creating an ecosystem for start-ups to thrive
Pickavance Lecture Theatre | Main Stage
Oxfordshire has a vibrant community of young and early stage companies, with many new ones created each year. Many of these are spin-outs from Oxford’s two Universities and benefit greatly from the support of their parent institutions. However, many companies start without the backing of Oxfordshire’s universities or decide to locate within the Oxfordshire region to grow and develop their innovation. This panel will look at the ecosystem for start-ups, considering how companies gain support and grow, and will examine the strengths and weaknesses of Oxfordshire as a place for start-ups to scale and succeed.
Panellists: Mark Evans – Adaptix, Jon Rees – MitoRx Therapeutics, Nicki Campling – Barclays Eagle Labs, Oxford, Jens Tholstrup – OION, Megan Morys-Carter – TheHill and Gillian McLaren – British Business Bank.
Chaired by Nicola McConville – Taylor Vinters.
Sponsored by British Business Bank, James Cowper Kreston and Taylor Vinters.